199 related articles for article (PubMed ID: 29517866)
1. [Subtrochanteric pathological fracture on bisphosphonates].
Mathonet PY; Willems S; Ciornohac JF
Rev Med Liege; 2018 Feb; 73(2):56-60. PubMed ID: 29517866
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
Sánchez A; Blanco R
Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
[TBL] [Abstract][Full Text] [Related]
3. [Treatment with bisphosphonates as a possible cause of bilateral spontaneous atypical femoral fracture].
Rasmussen M; Lange J
Ugeskr Laeger; 2012 Jan; 174(1-2):32-3. PubMed ID: 22233718
[TBL] [Abstract][Full Text] [Related]
4. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
5. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Rizzoli R; Akesson K; Bouxsein M; Kanis JA; Napoli N; Papapoulos S; Reginster JY; Cooper C
Osteoporos Int; 2011 Feb; 22(2):373-90. PubMed ID: 21085935
[TBL] [Abstract][Full Text] [Related]
6. Atypical subtrochanteric fractures after long-term bisphosphonate therapy.
Czerwiński E
Endokrynol Pol; 2011; 62(1):84-7. PubMed ID: 21365585
[TBL] [Abstract][Full Text] [Related]
7. Salvage of failed osteosynthesis for an atypical subtrochanteric femoral fracture associated with long-term bisphosphonate treatment using a 95° angled blade plate.
Kim SM; Rhyu KH; Lim SJ
Bone Joint J; 2018 Nov; 100-B(11):1511-1517. PubMed ID: 30418051
[TBL] [Abstract][Full Text] [Related]
8. Evolving data about subtrochanteric fractures and bisphosphonates.
Shane E
N Engl J Med; 2010 May; 362(19):1825-7. PubMed ID: 20335574
[No Abstract] [Full Text] [Related]
9. Bisphosphonate-induced atypical subtrochanteric femoral fracture.
Vaishya R; Vaish A; Nadeem A
BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24287483
[TBL] [Abstract][Full Text] [Related]
10. [Atypical subtrochanteric femur fracture under alendronate therapy in spite of an intramedullar implant].
Sobotta HP; Gösling T
Unfallchirurg; 2017 Feb; 120(2):171-175. PubMed ID: 27812727
[TBL] [Abstract][Full Text] [Related]
11. Atypical subtrochanteric fractures in Korean hip fracture study.
Lee YK; Kim TY; Ha YC; Song SH; Kim JW; Shon HC; Chang JS; Koo KH
Osteoporos Int; 2017 Oct; 28(10):2853-2858. PubMed ID: 28612307
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
[TBL] [Abstract][Full Text] [Related]
13. Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates.
Skoglund K; Hjortdal O
Tidsskr Nor Laegeforen; 2015 Jan; 135(2):116-7. PubMed ID: 25625987
[No Abstract] [Full Text] [Related]
14. Bisphosphonate-related subtrochanteric femoral fractures.
Gunawardena I; Baxter M; Rasekh Y
Am J Geriatr Pharmacother; 2011 Jun; 9(3):194-8. PubMed ID: 21470918
[TBL] [Abstract][Full Text] [Related]
15. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
Ing-Lorenzini K; Desmeules J; Plachta O; Suva D; Dayer P; Peter R
Drug Saf; 2009; 32(9):775-85. PubMed ID: 19670917
[TBL] [Abstract][Full Text] [Related]
16. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT.
Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082
[TBL] [Abstract][Full Text] [Related]
17. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
[TBL] [Abstract][Full Text] [Related]
18. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
Puhaindran ME; Farooki A; Steensma MR; Hameed M; Healey JH; Boland PJ
J Bone Joint Surg Am; 2011 Jul; 93(13):1235-42. PubMed ID: 21776577
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates and atypical femoral fractures.
Silverman SL; Ott SM; Dell RM
N Engl J Med; 2010 Sep; 363(11):1083; author reply 1084-5. PubMed ID: 20825324
[No Abstract] [Full Text] [Related]
20. [Atypical subtrochanteric fractures after long-term bisphosphonate therapy].
Czerwiński E
Endokrynol Pol; 2011; 62 Suppl 2():42-5. PubMed ID: 22125022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
